Skip Navigation


JAC Advance Access originally published online on October 5, 2006
Journal of Antimicrobial Chemotherapy 2006 58(6):1193-1197; doi:10.1093/jac/dkl408
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
58/6/1193    most recent
dkl408v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (11)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Keiser, J.
Right arrow Articles by Vennerstrom, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Keiser, J.
Right arrow Articles by Vennerstrom, J. L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

The synthetic peroxide OZ78 is effective against Echinostoma caproni and Fasciola hepatica

Jennifer Keiser1,*, Jürg Utzinger1, Marcel Tanner1, Yuxiang Dong2 and Jonathan L. Vennerstrom2

1 Swiss Tropical Institute, PO Box CH-4002 Basel, Switzerland 2 College of Pharmacy, University of Nebraska Medical Center Nebraska, NE 68198-6025, USA

Received 14 July 2006; returned 27 August 2006; revised 1 September 2006; accepted 12 September 2006


*Corresponding author. Tel: +41-61-284-8218; Fax: +41-61-284-8105; E-mail: jennifer.keiser{at}unibas.ch

Objectives: The trematocidal properties of a synthetic peroxide, 1,2,4-trioxolane (OZ78) were determined both in vivo and in vitro.

Methods: Two weeks post-infection Echinostoma caproni-infected mice were administered single oral doses of 400–1000 mg/kg OZ78. Fasciola hepatica-infected rats were treated orally with 50–400 mg/kg OZ78 3 and 8–9 weeks post-infection. Worm burden reductions were assessed against untreated control animals. Adult F. hepatica were observed by scanning electron microscopy (SEM) after recovery from the bile duct of a rat 3 days after administration of a single oral dose of 100 mg/kg OZ78 and after in vitro exposure to concentrations of 1, 10 and 100 µg/mL OZ78.

Results: In the E. caproni–mouse model 100% worm burden reductions were achieved with a single oral dose of 1000 mg/kg OZ78. A single dose of 100 mg/kg OZ78 resulted in worm burden reductions of 100% against juvenile and adult F. hepatica. F. hepatica recovered from rats 3 days post-treatment displayed feeble activity and some flukes had died. Typical features revealed by SEM included extensive blebbing and sloughing. Exposure of F. hepatica to 10–100 µg/mL OZ78 in vitro resulted in the death of all trematodes. F. hepatica showed focal blebbing and sloughing of the tegument at all concentrations investigated.

Conclusions: Our data indicate that OZ78 is highly efficacious against F. hepatica and E. caproni and provide a sound platform for identification of a synthetic peroxide drug development candidate against major trematode infections.

Keywords: food-borne trematodiasis , 1,2,4-trioxolanes , in vivo studies , in vitro studies , scanning electron microscopy


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Antimicrob. Agents Chemother.Home page
J. Keiser, S.-H. Xiao, T. A. Smith, and J. Utzinger
Combination Chemotherapy against Clonorchis sinensis: Experiments with Artemether, Artesunate, OZ78, Praziquantel, and Tribendimidine in a Rat Model
Antimicrob. Agents Chemother., September 1, 2009; 53(9): 3770 - 3776.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
J. Keiser and J. Utzinger
Food-Borne Trematodiases
Clin. Microbiol. Rev., July 1, 2009; 22(3): 466 - 483.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
J. Keiser, M.-S. Gruyer, N. Perrottet, B. Zanolari, T. Mercier, and L. Decosterd
Pharmacokinetic parameters of artesunate and dihydroartemisinin in rats infected with Fasciola hepatica
J. Antimicrob. Chemother., March 1, 2009; 63(3): 543 - 549.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
S.-H. Xiao, J. Keiser, J. Chollet, J. Utzinger, Y. Dong, Y. Endriss, J. L. Vennerstrom, and M. Tanner
In Vitro and In Vivo Activities of Synthetic Trioxolanes against Major Human Schistosome Species
Antimicrob. Agents Chemother., April 1, 2007; 51(4): 1440 - 1445.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.